AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Investigational Drug Combinations for Pancreatic Cancer and Microbiome-Based Immunotherapy in Cancer Treatment
The chapter explores the FDA clearance of an investigational new drug for a clinical trial treating advanced pancreatic cancer with a innovative drug combination. Also, Biomica's progress in a Phase 1 trial for BMC 128 in conjunction with immune checkpoint inhibitors for cancer patients is highlighted, showcasing promising advancements in cancer therapy.